References
- O’KeefeSJBuchmanALFishbeinTMJeejeebhoyKNJeppesenPBShafferJShort bowel syndrome and intestinal failure: consensus definitions and overviewClin Gastroenterol Hepatol20064161016431298
- CarbonnelFCosnesJChevretSThe role of anatomic factors in nutritional autonomy after extensive small bowel resectionJPEN J Parenter Enteral Nutr19962042752808865109
- HowardLHome parenteral nutrition: survival, cost, and quality of lifeGastroenterology20061302 Suppl 1S52S5916473073
- ESPEN-Home Artificial Nutrition Working GroupVan GossumABakkerHHome parenteral nutrition in adults: a multicentre survey in Europe in 1993Clin Nutr1996152535916843998
- PereiraPMBinesJENew growth factor therapies aimed at improving intestinal adaptation in short bowel syndromeJ Gastroenterol Hepatol200621693294016724975
- JeppesenPBGilroyRPertkiewiczMAllardJPMessingBO’KeefeSJRandomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndromeGut201160790291421317170
- JeppesenPBPertkiewiczMMessingBTeduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failureGastroenterology2012143614731481. e322982184
- MatareseLEJeppesenPBO’KeefeSJShort bowel syndrome in adults: the need for an interdisciplinary approach and coordinated careJPEN J Parenter Enteral Nutr2014381 Suppl60S64S24418899
- BuchmanALScolapioJFryerJAGA technical review on short bowel syndrome and intestinal transplantationGastroenterology200312441111113412671904
- O’KeefeSJPetersonMEFlemingCROctreotide as an adjunct to home parenteral nutrition in the management of permanent end-jejunostomy syndromeJPEN J Parenter Enteral Nutr199418126348164299
- O’KeefeSJHaymondMWBennetWMOswaldBNelsonDKShorterRGLong-acting somatostatin analogue therapy and protein metabolism in patients with jejunostomiesGastroenterology199410723793887518781
- ByrneTAWilmoreDWIyerKGrowth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome: a prospective, randomized, placebo-controlled, double-blind clinical trialAnn Surg2005242565566116244538
- WalesPWNasrAde SilvaNYamadaJHuman growth hormone and glutamine for patients with short bowel syndromeCochrane Database Syst Rev2010166CD00632120556765
- TappendenKAIntestinal adaptation following resectionJPEN J Parenter Enteral Nutr2014381 Suppl23S31S24586019
- RowlandKJBrubakerPLThe “cryptic” mechanism of action of glucagon-like peptide-2Am J Physiol Gastrointest Liver Physiol20113011G1G821527727
- YazbeckRHowarthGSAbbottCAGrowth factor based therapies and intestinal disease: is glucagon-like peptide-2 the new way forward?Cytokine Growth Factor Rev200920217518419324585
- VipperlaKO’KeefeSJTeduglutide for the treatment of short bowel syndromeExpert Rev Gastroenterol Hepatol20115666567822017694
- ScottRBKirkDMacNaughtonWKMeddingsJBGLP-2 augments the adaptive response to massive intestinal resection in ratAm J Physiol19982755 Pt 1G911G9219815019
- JeppesenPBSanguinettiELBuchmanATeduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patientsGut20055491224123116099790
- O’KeefeSJJeppesenPBGilroyRPertkiewiczMAllardJPMessingBSafety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal failureClin Gastroenterol Hepatol2013117815.e1823.e323333663
- CompherCGilroyRPertkiewiczMMaintenance of parenteral nutrition volume reduction, without weight loss, after stopping teduglutide in a subset of patients with short bowel syndromeJPEN J Parenter Enteral Nutr201135560360921825090
- NPS PharmaceuticalsPioneering and delivering therapies that transform the lives of patients with rare diseases worldwide2013 Available from: http://www.npsp.com/file_depot/0-10000000/0-10000/262/folder/2023/Investor+Slide+Deck.pdfAccessed November 19, 2014
- NaveRHalabiAHerzogRPharmacokinetics of teduglutide in subjects with renal impairmentEur J Clin Pharmacol20136951149115523187965
- JeppesenPBPertkiewiczMForbesAQuality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide – analyses from a randomised, placebo-controlled studyClin Nutr201332571372123587733